Amanullah A M, Berman D S, Erel J, Kiat H, Cohen I, Germano G, Friedman J D, Hachamovitch R
Department of Imaging, Cedars-Sinai Medical Center, University of California, Los Angeles School of Medicine, 90048, USA.
Am J Cardiol. 1998 Sep 15;82(6):725-30. doi: 10.1016/s0002-9149(98)00463-9.
Adenosine myocardial perfusion single-photon emission computed tomography (SPECT) is now increasingly used for risk stratification of patients with known or suspected coronary artery disease. However, the incremental prognostic value of this test over clinical and historical information in a large series of women has not been examined. Thus, we studied 923 consecutive women who underwent adenosine technetium (Tc)-99m sestamibi myocardial perfusion SPECT and were followed-up for a mean period of 26+/-8 months. During the follow-up period, 77 hard events (46 cardiac deaths and 31 nonfatal myocardial infarctions) occurred. The results of the perfusion scan significantly risk stratified the population; patients with normal scans had a low rate of nonfatal myocardial infarction and cardiac death (< 1%/year of follow up). Patients with mildly abnormal scans had low cardiac death rates (0.9%/year of follow up); these rates increased as a function of scan abnormality (4.1% and 7.5% mortality per year of follow up in moderate and severely abnormal scans). Cox proportional hazards analysis demonstrated that after adjusting for prior myocardial infarction and diabetes mellitus (the most predictive individual clinical variables [global chi-square=22.5, p <0.001]), as well as heart rate at rest (the most predictive physiologic variable [chi-square=3.8; p=0.05]), the most predictive nuclear variable (summed stress score [chi-square=48.5; p <0.0001]) added significant incremental prognostic information (global chi-square increased from 22.5 to 56.2 [p <0.0001]). In conclusion, adenosine myocardial perfusion SPECT added significant incremental prognostic information to clinical and physiologic variables in women. Normal scans were associated with an excellent prognosis. In contrast, patients with moderately to severely abnormal scans were at a higher risk for future cardiac events.
腺苷心肌灌注单光子发射计算机断层扫描(SPECT)目前越来越多地用于已知或疑似冠心病患者的危险分层。然而,在一大群女性中,该检查相对于临床和病史信息的增量预后价值尚未得到研究。因此,我们研究了923例连续接受腺苷锝(Tc)-99m 甲氧基异丁基异腈心肌灌注SPECT检查且平均随访26±8个月的女性。在随访期间,发生了77例严重事件(46例心源性死亡和31例非致命性心肌梗死)。灌注扫描结果对人群进行了显著的危险分层;扫描正常的患者非致命性心肌梗死和心源性死亡发生率较低(随访每年<1%)。扫描轻度异常的患者心源性死亡率较低(随访每年0.9%);这些比率随着扫描异常程度增加而上升(中度和重度异常扫描患者随访每年死亡率分别为4.1%和7.5%)。Cox比例风险分析表明,在调整了既往心肌梗死和糖尿病(最具预测性的个体临床变量[总体卡方=22.5,p<0.001])以及静息心率(最具预测性的生理变量[卡方=3.8;p=0.05])后,最具预测性的核医学变量(总负荷评分[卡方=48.5;p<0.0001])增加了显著的增量预后信息(总体卡方从22.5增加到56.2[p<0.0001])。总之,腺苷心肌灌注SPECT为女性的临床和生理变量增加了显著的增量预后信息。正常扫描与良好的预后相关。相比之下,中度至重度异常扫描的患者未来发生心脏事件的风险更高。